Modelling the daily risk of Ebola in the presence and absence of a potential vaccine
Ebola virus — one of the deadliest viral diseases, with a mortality rate around 90% — damages the immune system and organs, with symptoms including episodic fever, chills, malaise and myalgia. The Recombinant Vesicular Stomatitis Virus-based candidate vaccine (rVSV-ZEBOV) has demonstrated clinical e...
Main Authors: | Stéphanie M.C. Abo, Robert Smith? |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2020-01-01
|
Series: | Infectious Disease Modelling |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468042720300579 |
Similar Items
-
Is a COVID-19 Vaccine Likely to Make Things Worse?
by: Stéphanie M. C. Abo, et al.
Published: (2020-12-01) -
Ebola Virus Disease
by: Necla TÜLEK, et al.
Published: (2015-06-01) -
Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola
by: Jennifer K. Legardy-Williams, et al.
Published: (2020-03-01) -
Structural and Functional Aspects of Ebola Virus Proteins
by: Sahil Jain, et al.
Published: (2021-10-01) -
Ebola Virus Disease Vaccines: Development, Current Perspectives & Challenges
by: Sumira Malik, et al.
Published: (2023-01-01)